- CYCC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Cyclacel Pharmaceuticals (CYCC) 10-K/A2009 FY Annual report (amended)
Filed: 17 May 10, 12:00am
(i) | the Amendment No. 1 to the Annual Report on Form 10-K/A of the Company for the year ended December 31, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and | ||
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 17, 2010 | /s/ Spiro Rombotis | |||
Spiro Rombotis | ||||
President & Chief Executive Officer | ||||
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.